Share Twitter LinkedIn Facebook Email Do-Youn Oh, M.D., of Seoul National University Hospital discusses Pembrolizumab Monotherapy In Biliary Cancer. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
Gastric Cancer Immunotherapy Breakthroughs: Dr. Iqbal on MATTERHORN Gastrointestinal Cancer Treatment 3 Mins Read